• Something wrong with this record ?

Biochanin A, the Most Potent of 16 Isoflavones, Induces Relaxation of the Coronary Artery Through the Calcium Channel and cGMP-dependent Pathway

T. Migkos, J. Pourová, M. Vopršalová, C. Auger, V. Schini-Kerth, P. Mladěnka,

. 2020 ; 86 (10) : 708-716. [pub] 20200514

Language English Country Germany

Document type Journal Article

Grant support
EFSA-CDN project CZ.02.1.01/0.0/0.0/16_019/0000841
Univerzita Karlova v Praze SVV 260 414

The dietary intake of flavonoids seems to be inversely related to cardiovascular mortality. The consumption of isoflavonoids is increasing in the general population, especially due to the use of food supplements and a variety of isoflavonoid-rich foods. However, detailed studies on the vascular influence of individual pure isoflavonoids are mostly missing. For this study, 16 isoflavonoids were initially screened for their vasorelaxant properties on rat aortas. The 2 most potent of them, biochanin A and glycitein, were further tested for the mechanism of action on porcine coronary arteries. They both induced an endothelium independent vascular relaxation, with EC50 below 6 and 17 µM, respectively. Biochanin A, but not glycitein, was able to block the vasoconstriction caused by KCl, CaCl2, serotonin, and U46619 in a dose-dependent manner. Another series of experiments suggested that the major mechanism of action of biochanin A was the inhibition of L-type calcium channels. Moreover, biochanin A in relatively small concentrations (2 - 4 µM) interfered with the cGMP, but not cAMP, pathway in isolated coronary arteries. These results indicate that some isoflavonoids, in particular biochanin A, are able to have vasodilatory effects in micromolar concentrations, which is of potential clinical interest for the management of cardiovascular pathologies.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20024933
003      
CZ-PrNML
005      
20201222160036.0
007      
ta
008      
201125s2020 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1055/a-1158-9422 $2 doi
035    __
$a (PubMed)32408360
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Migkos, Thomas $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
245    10
$a Biochanin A, the Most Potent of 16 Isoflavones, Induces Relaxation of the Coronary Artery Through the Calcium Channel and cGMP-dependent Pathway / $c T. Migkos, J. Pourová, M. Vopršalová, C. Auger, V. Schini-Kerth, P. Mladěnka,
520    9_
$a The dietary intake of flavonoids seems to be inversely related to cardiovascular mortality. The consumption of isoflavonoids is increasing in the general population, especially due to the use of food supplements and a variety of isoflavonoid-rich foods. However, detailed studies on the vascular influence of individual pure isoflavonoids are mostly missing. For this study, 16 isoflavonoids were initially screened for their vasorelaxant properties on rat aortas. The 2 most potent of them, biochanin A and glycitein, were further tested for the mechanism of action on porcine coronary arteries. They both induced an endothelium independent vascular relaxation, with EC50 below 6 and 17 µM, respectively. Biochanin A, but not glycitein, was able to block the vasoconstriction caused by KCl, CaCl2, serotonin, and U46619 in a dose-dependent manner. Another series of experiments suggested that the major mechanism of action of biochanin A was the inhibition of L-type calcium channels. Moreover, biochanin A in relatively small concentrations (2 - 4 µM) interfered with the cGMP, but not cAMP, pathway in isolated coronary arteries. These results indicate that some isoflavonoids, in particular biochanin A, are able to have vasodilatory effects in micromolar concentrations, which is of potential clinical interest for the management of cardiovascular pathologies.
650    _2
$a zvířata $7 D000818
650    _2
$a vápník $7 D002118
650    12
$a vápníkové kanály $7 D015220
650    _2
$a koronární cévy $7 D003331
650    _2
$a cévní endotel $7 D004730
650    _2
$a genistein $7 D019833
650    _2
$a lidé $7 D006801
650    12
$a isoflavony $7 D007529
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a prasata $7 D013552
650    _2
$a vazodilatace $7 D014664
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pourová, Jana $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
700    1_
$a Vopršalová, Marie $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
700    1_
$a Auger, Cyril $u INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS, Université de Strasbourg, Faculté de Pharmacie, Illkirch, France.
700    1_
$a Schini-Kerth, Valérie $u INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS, Université de Strasbourg, Faculté de Pharmacie, Illkirch, France.
700    1_
$a Mladěnka, Přemysl $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
773    0_
$w MED00003839 $t Planta medica $x 1439-0221 $g Roč. 86, č. 10 (2020), s. 708-716
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32408360 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222160032 $b ABA008
999    __
$a ok $b bmc $g 1599078 $s 1115619
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 86 $c 10 $d 708-716 $e 20200514 $i 1439-0221 $m Planta medica $n Planta Med $x MED00003839
GRA    __
$a EFSA-CDN project $p CZ.02.1.01/0.0/0.0/16_019/0000841
GRA    __
$a Univerzita Karlova v Praze $p SVV 260 414
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...